Description
Semaglutide (Ozempic) is a synthetic GLP-1 analog peptide studied for its metabolic effects, including:
• Appetite regulation via delayed gastric emptying
• Enhanced insulin secretion with glucose-dependent action
• Potential weight management mechanisms
This research compound mimics natural incretin hormones to support studies in:
✔️ Metabolic syndrome pathways
✔️ Glucose homeostasis
✔️ Satiety signaling systems
For research purposes only. Not for human consumption.
Reviews
There are no reviews yet.